PRINCIPLES OF EVIDENCE MEDICINE IN COMPLEX THERAPY FOR DIABETIC POLYNEUROPATHY

Authors

  • Kravchun N. A. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv

DOI:

https://doi.org/10.21856/j-PEP.2015.3.17

Keywords:

diabetic polyneuropathy, diabetic retinopathy, glycosylated hemoglobin, insulin resistance

Abstract

Diabetic polyneuropathy (DPN) is the most common chronic complication of diabetes mellitus. It is known that DPN not only significantly reduces the quality of life of patients, but also causes more formidable consequences of the disease - diabetic foot syndrome and limb amputation. Given the key role of hyperglycemia in the pathogenesis of DPN, the main direction in the prevention and treatment of this condition is adequate control of blood glucose and glycosylated hemoglobin (HbA1c) levels.

References

Greb A, Bitsch R. Int J Clin Pharmacol Ther 1998; 36(4):216-221.

Kravchun NA, Kazakov AV. Mezhdunar Jendokrinol Zhurn 2007; 3(9):88-91.

Brownlee M. A Unifying Mechanism Diabetes 2005; 54(6):1615-1625.

Hammes HP, Du X, Edeistein D, et al. Nat Med 2003; 9:294-299.

Stracke H, Hammes HP, Werkmann K, et al. Exp Clin Endocrinol Diab 2001; 109:330-336.

Malyj VD. Mezhdunar Nevrol Zhurn 2006; 2(6):41-46.

Sergijenko VO, Segin VB, Azhmi Samir, Sergijenko OO. Klinichna Endokrynologija ta Endokrynna Hirurgija 2013; 3(43):35-40.

Papanas N, Ziegler D. Mizhnar Nevrol Zhurn 2015; 2(72):1-20.

Du X, Edelstein D, Obici S, et al. Clin Invest 2006; 116:1071-1080.

Thornalley PJ, Jahan I, Ng R. J Biochem 2001; 129:543-549.

Androne L, Gavan NA, Veresiu IA, et al. In Vivo 2000; 14(2):327-330.

Ziegler D. Treat Endocrinol 2004; 3(3):173-189.

Thirunavukkarasu V, et al. Pharmazie 2005; 60(10):772-775.

Kempler P, Tesfaye S, Chaturvedi N, et al. Diabet Med 2002; 19:900-909.

Ying Z, Kampfrath T, Sun Q, et al. Inflamm Res 2011; 60:219-225.

Golbidi S, Badran M, Laher I. Diabet. Ozhirenie. Metabolicheskij Sindrom 2012; 1:48-58.

Afanas’ev D. Novaja Medicina Tysjacheletija 2009; 1:7-9.

Heitzer T, Finckh B, Albers S, et al. Free Radic Biol Med 2001; 31:53-61.

Caballero AE. Obes Res 2003; 11:1278-1289.

Kamenova P. Hormones (Athens) 2006; 5:251-258.

Ametov AS, Novosadova MV, Barinov AN, et al. H J Ter Arkh 2010; 82:61-64.

De Oliveira AM, Rondó PH, Luzia LA, et al. Diabetes Res Clin Pract 2011; 92:253-260.

Koh EH, Lee WJ, Lee SA, et al. Am J Med 2011; 124:851-858.

Ansar H, Mazloom Z, Kazemi F, et al. Saudi Med J 2011; 32:584-588.

Heinisch BB, Francesconi M, Mittermayer F, et al. Eur J Clin Invest 2010; 40:148-154.

Zhang Y, Han P, Wu H, et al. Obesity (Silver Spring) 2011; 19:1647-1653.

Gianturco V, Bellomo A, D’Ottavio E, et al. Arch Gerontol Geriatr 2009; 49:129-133.

Verkin AL, Zorina SA, Novikova IM, et al. Consilium Medicum 2008; 10(4):47-50.

Saenz De Tajada, Blanco R, Goldstein I, et al. Am J Physiol 1988; 254:468-472.

Veves A, Akbari CM, Primavera J, et al. Diabetes 1998; 47(3):457-463.

Galstjan GR, Anciferov MB. Saharnyj Diabet 2001; 2:10-13.

Abdelmalek MF, Suzuki A, Gui C, et al. Hepatology 2010; 51:1961-1971.

Horoshinina LP. Zhirovoe povrezhdenie pecheni i ishemicheskaja bolezn’ serdca. Geriatricheskie aspekty: monografija, Moskva , 2014: 346 p.

Haumov TL, Miljutina TL, Ostapenko TS, et al. Mezhdunar Jendokrinol Zhurn 2007; 4(10):48-54.

Varkon’i T, Kempler P, Man’kovskij B. Diabet, Ozhyrinnja, Metabolichnyj Syndrom 2014; 4(III):42-48.

Downloads

Published

2021-08-17

How to Cite

Kravchun, N. A. . (2021). PRINCIPLES OF EVIDENCE MEDICINE IN COMPLEX THERAPY FOR DIABETIC POLYNEUROPATHY. Problems of Endocrine Pathology, 53(3), 133-138. https://doi.org/10.21856/j-PEP.2015.3.17

Issue

Section

TO PRACTICING ENDOCRINOLOGISTS